What IDI Farmaceutici does

IDI Farmaceutici is an Italian pharmaceutical and dermocosmetics company with heritage dating to 1857 and formal establishment in Pomezia in 1966. It operates a 50,000 sq m integrated production facility and employs more than 150 people, manufacturing across five product categories: prescription dermatology pharmaceuticals, over-the-counter dermocosmetics, medical devices, dietary supplements, and sun care. Its product portfolio is anchored by proprietary formulations including Dual Booster, Nicoxantine, and ReflexVit, and the company carries AIFA GMP authorization, UNI EN ISO 9001 certification, CE Marking for medical devices, and IRCCS recognition granted in 1990.

The business operates a hybrid revenue model combining B2B contract manufacturing and licensing for major pharmaceutical companies (Merck & Co, Viatris, LEO Pharma, Almirall Hermal, Polifarma) with B2C distribution through Italian pharmacies. Distribution is extended via the Polifarma pharmacy network and the Theriaca hospital pharmacy partnership, supplemented by an e-commerce presence (farmaidi.it). International revenues are generated through licensing arrangements across the Balkans, Central Asia, the Caucasus, and South Korea, providing geographic diversification beyond the Italian home market. In 2024, SPA Società Prodotti Antibiotici acquired a 40% minority stake, injecting growth capital and signaling strategic alignment with a peer Italian pharmaceutical operator.

Name

IDI Farmaceutici

Legal name

IDI Farmaceutici S.r.l.

Website

https://idifarmaceutici.com

Company type

Private

Founded year

1857

Operating status

Operating

Headcount range

11–50 employees

Short description

IDI Farmaceutici is an Italian pharmaceutical and dermocosmetics company operating a 50,000 sq m facility in Pomezia, manufacturing prescription dermatology drugs, dermocosmetics, medical devices, supplements, and sun care for global pharma partners and Italian pharmacies.

Ownership category

akta.pro rank

Product category

Dermatological Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Surgical and Medical Instrument Manufacturing (339112), Pharmaceutical and Medicine Manufacturing (3254), Medical Equipment and Supplies Manufacturing (3391)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Dermatology Specialty Pharmaceuticals (HLAIACAL), Topical & Dermatology Generics (HLAIABAE), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Dermatological pharmaceuticals
• Dermocosmetic products
• Medical devices skincare
• Sun care formulations
• Contract pharmaceutical manufacturing

Headquarters

HQ city

Pomezia

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products: Manufacturing and sale of topical and oral drugs for dermatological conditions including dermatitis, eczema, acne, psoriasis, mycosis, skin infections, trichology, and actinic keratosis. Products sold through pharmacies and hospital pharmacies.
2. Dermocosmetics and Sun Care: Production and sale of dermocosmetic products including daily cleansing, moisturizers, brightening, dermoprotection, deodorants, and trichology lines. Also includes the Idisole sun care line with various SPF levels.
3. Medical Devices: Development and production of substance-based medical devices for topical treatment of skin conditions such as seborrheic dermatitis and wound treatment spray bandages.
4. Dietary Supplements: Production of dietary supplements formulated to strengthen body's natural defenses against oxidative stress, including Immugen capsules and granule formulations.
5. Contract Manufacturing: Manufacturing products on behalf of other important pharmaceutical companies. Every day thousands of product units are manufactured including topical and oral drugs, medical devices, and dermocosmetics for third parties.
6. Licensing and Distribution Partnerships: International licensing agreements with companies like Almirall Hermal GmbH, Viatris, and Theriaca for distribution of drugs in various dermatological areas. Commercial agreements with Polifarma for Italian market distribution.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

IDI Farmaceutici is a pharmaceutical manufacturer that develops, produces, and sells dermatological drugs (topical and oral medications), CE-marked medical devices, dermocosmetic products (cleansers, moisturizers, deodorants, trichology and baby care lines), the Idisole.it sun care line, and dietary supplements under the Immugen brand. It also operates contract manufacturing for other major pharmaceutical companies and licenses its dermatology products internationally through partners such as Almirall Hermal, Viatris, and Merck&Co.

Product overview

IDI Farmaceutici is a pharmaceutical and dermocosmetics company producing a diversified portfolio across five main product categories: Pharmaceuticals (medicines for dermatitis, eczema, acne, fungal infections, trichology, antihistamines, wound repair, and actinic keratosis), Dermocosmetics (skin care, cleansing, moisturizing, brightening, trichology, deodorants, and child dermoprotection products), Medical Devices (Nicotinamide DS Cream for seborrheic dermatitis and Citrizan DM Spray for wound care), Dietary Supplements (Immugen immune-support line), and Sun Care (Idisole.it line with specialized Nautilus and Children sub-lines). The company operates under the IDI Group with 150 years of dermatology research heritage and distributes internationally in the Balkans, South Korea, and other markets.

Differentiator

Problem solved

Functional benefit

Brands

• Gruppo IDI: Parent organization with 150 years of experience in dermatology research, encompassing clinical facilities, production, and online pharmacy services.

Products and services

• BETA 21 (Betamethasone 17-valerate 21-acetate cream/emulsion/ointment) Topical corticosteroid cream, emulsion, and ointment containing Betamethasone 17-valerate 21-acetate indicated for dermatitis, prescribed to patients via pharmacies and dermatologists.
• BIDIEN (Budesonide topical) Topical corticosteroid containing Budesonide for the treatment of eczema and dermatitis.
• DERMATAR (Salicylic acid, Ammonium sulfobituminate, Betamethasone ointment) Topical ointment combining Salicylic acid, Ammonium sulfobituminate, and Betamethasone 17-valerate 21-acetate for inflammatory and hyperkeratotic skin conditions.
• ELIDEL (Pimecrolimus cream) Topical cream containing Pimecrolimus indicated for atopic dermatitis.
• ACNATAC 10 (Clindamycin + Tretinoin gel) Topical gel combining Clindamycin and Tretinoin for the treatment of acne vulgaris.
• ERYTHROMYCIN IDI (topical antibiotic) Topical antibiotic cream, gel, and solution containing Erythromycin base for acne and skin infections.
• NOIDAK (Isotretinoin soft capsules) Isotretinoin soft capsules for the systemic treatment of severe acne.
• ZINCO SOLFATO IDI (Zinc Sulfate tablets) Zinc Sulfate tablets for oral administration in dermatological conditions.
• GENTAMICINA IDI (Gentamicin topical cream) Topical cream containing Gentamicin sulfate for the treatment of bacterial skin infections.
• GENTAMICINA E BETAMETASONE IDI (combination cream) Topical cream combining Gentamicin sulfate and Betamethasone valerate for infected inflammatory skin conditions.
• DECODERM (Miconazole + Fluprednidene cream) Topical cream combining Miconazole nitrate and Fluprednidene-21-acetate for fungal skin infections with inflammatory component.
• ZERFUN (Fluconazole capsules 100/150/200 mg) Oral Fluconazole capsules in 100 mg, 150 mg, and 200 mg strengths for the treatment of systemic fungal infections.
• NICOTINAMIDE IDI (250 mg tablets) Oral Nicotinamide 250 mg tablets indicated for photoprotection and skin health support.
• ALOXIDIL (Minoxidil solution) Topical Minoxidil solution for the treatment of androgenetic alopecia and other hair-loss conditions.
• CISTIDIL (L-Cystine 500 mg tablets) Oral L-Cystine 500 mg tablets supporting hair and skin health in trichology indications.
• STAMIDIX (Cetirizine tablets and oral drops) Antihistamine tablets and oral drops containing Cetirizine Dihydrochloride for the treatment of allergic dermatological conditions.
• CITRIZAN (Equine catalase gel) and CITRIZAN ANTIBIOTIC Topical gel containing Equine catalase for wound and burn repair; also available as CITRIZAN ANTIBIOTIC with added Gentamicin for infected wounds.
• FERTOMCIDINA U (Salicylic Acid + Sodium Iodide cutaneous solution) Cutaneous solution containing Salicylic Acid and Sodium Iodide for wound care applications.
• ZYCLARA (Imiquimod 3.75% cream) Topical Imiquimod 3.75% cream for the treatment of actinic keratosis.
• Idisole.it Sun Care Line Sun protection line including face cream SPF 50+, after-sun body cream, Nicox SPF30 and SPF50+ sprays, and hair/body oil SPF6, featuring Nicotinamide and Dual Booster Technology for combined photoprotection and anti-aging action.
• Idisole.it Nautilus Line Specialized sun protection line for marine and water-sports enthusiasts, including face cream SPF 50+, after-sun spray, and SPF 50+ spray milk with enhanced water resistance.
• Idisole.it Children Line Pediatric sun care line with SPF 50+ and after-sun products featuring Dual Booster Technology with Nicotinamide and Astaxanthin (Nicoxantine Complex).
• Idisole.it Nicox Advanced sun protection products combining SPF filters with the anti-aging Nicotinamide complex (Nicoxantine Complex).
• Immugen Dietary Supplements Antioxidant supplement line with immune-supportive action that strengthens the body's natural defenses against oxidative stress, available in capsule and granular forms.
• NICOTINAMIDE DS CREAM (medical device) CE-marked medical device cream containing Nicotinamide, ceramides, lithium gluconate, and shea butter for adjuvant treatment of seborrheic dermatitis with soothing, skin-protective, and regenerating effects.
• Citrizan DM Spray (spray plaster medical device) Spray plaster medical device creating a protective, soothing, breathable barrier for wound treatment, formulated with collagen and hyaluronic acid.
• RIVIGEN Oligoshampoo Line Trichology shampoo line based on marine trace elements and Niacinamide, including Baby, Dandruff, Delicate, Oily, and Anti-Hair Loss variants.
• Idideo Deodorant Line Deodorant line including Classic (24-hour protection), Intensive (alcohol-free antiperspirant), and Sensitive (for delicate skin) variants.
• Soagen Moisturizing Line Hydration line with emollient and moisturizing components forming a barrier against transepidermal water loss, for face and body.
• Decortil Line Moisturizing line for sensitive skin with products suitable for adults and children, including a complement for atopic dermatitis treatment.
• Reparantine Line Moisturizing and emollient line based on natural ingredients for the relief of dry and flaky skin.
• Soagen Cleansing Line and Solid Cleansers (Syndet) Gentle cleansers for vulnerable and sensitive skin types (dry, sensitive, atopy-prone, and oily skin) plus soap-free solid syndet bars allowing pH modulation for different skin types.
• Idisan Hand Sanitizers Hand sanitizers with high ethyl alcohol concentration for germ and bacteria protection.
• Cold Cream IDI and IDIBASE CREAM Emollient and protective base creams: Cold Cream IDI with beeswax for very dry and dehydrated skin, and IDIBASE CREAM with shea butter for dry skin and barrier function restoration.
• IDILEN (children's protective cream) Protective and emollient cream for sensitive children's skin, formulated with shea butter and bisabolol.
• IDIPAST (zinc oxide protective paste) Protective paste containing 14.60% Zinc Oxide for diaper dermatitis and exudative dermatosis in babies.
• Contract Manufacturing Services for Pharmaceutical Companies B2B contract manufacturing of topical and oral drugs, medical devices, and dermocosmetics for other major pharmaceutical companies at the GMP-certified 50,000 sq m Pomezia plant, producing thousands of units daily.
• International Dermatology Licensing and Distribution Partnerships International licensing of dermatology drugs and medical devices to pharmaceutical partners such as Almirall Hermal GmbH and Viatris, plus distribution presence in Albania, Kosovo, Kazakhstan, Azerbaijan, Georgia, and South Korea.
• Farmaidi.it Online Pharmacy IDI-operated online pharmacy (farmaidi.it) allowing end consumers to find and order products directly, with a store locator for nearby physical pharmacies.

Quantifiable outcome

• Thousands of product units manufactured daily including topical and oral drugs, medical devices, and dermocosmetics
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eight partnerships are on record, tiered core, major and minor.

• ViatriscoreStrategic or Co-development Partner · 1 January 2023Important partnership established with Viatris for the licensing of a wide panel of drugs in the dermatological area. The joint venture represents a further piece of the mosaic built by IDI Group to interpret its role in pharmaceutical research with dynamism and constant evolution.
• Almirall Hermal GmbHcoreOEM/ Whitelabel/ Licensing Partner · 1 January 2021Significant agreement signed with Almirall Hermal GmbH for the licensing of important drugs in various dermatological areas (2021-2022).
• TheriacamajorChannel Partner/ Reseller/ Distributor · 1 January 2021New commercial agreement signed with Theriaca for distribution in the hospital pharmacy channel throughout Italy.
• Polifarma and Polifarma Benessere (FINAL group)majorChannel Partner/ Reseller/ Distributor · 1 January 2013Commercial agreement with Italian companies Polifarma and Polifarma Benessere, part of the FINAL group. Collaboration deepened over the years with distribution agreements that allowed IDI Farmaceutici to have a widespread presence throughout Italy.
• Merck&CocoreStrategic or Co-development Partner · 1 January 2011The multinational Merck&Co chose the IDI Group for an important collaboration agreement in the dermatological field. The partnership involved research and development of molecules of great therapeutic importance such as oncolytics and antineoplastics, as well as programs in the field of tissue regeneration and cellular biotechnology. Cutting-edge studies aimed at leading to the creation of cell-based preparations for serious chronic degenerative diseases.
• Nerviano Medical Sciences MNS Group & SpacoreStrategic or Co-development Partner · 1 January 2009The group acquired the clinical and preclinical research center Nerviano Medical Sciences MNS Group & Spa, expanding research capabilities.
• LEO PharmaminorOthersIDI Farmaceutici handles pharmacovigilance reporting for suspected adverse reactions related to the use of LEO Pharma medicines. Contact number 06 77 20 90 20 or email [email protected] for IDI products.
• Protection Trade S.r.l.minorOthersThe Data Protection Officer (DPO) for IDI Farmaceutici is Protection Trade S.r.l., located at Via Giorgio Morandi 22, 04022 ITRI (LT), contactable at [email protected].

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Cantabria Labs: Spanish dermatology-focused pharmaceutical and dermocosmetic company (Heliocare, Neoretin, Biretix) selling through pharmacy channels across Europe and Latin America; directly comparable in dermocosmetic positioning anchored in dermatology science.
• Almirall: Barcelona-based specialty pharmaceutical company focused exclusively on dermatology across Europe; IDI has a direct licensing agreement with its Almirall Hermal GmbH unit, making it both partner and closest head-to-head competitor in dermatology Rx and OTC.
• LEO Pharma: Danish global dermatology specialist with a broad portfolio in psoriasis, eczema, acne and skin infections; IDI provides pharmacovigilance support for LEO Pharma products in Italy and competes across overlapping therapeutic categories.
• Cassiopea (Cosmo Pharmaceuticals): Italy-based specialty pharma that built a dermatology franchise around topical treatments (Winlevi, Aktipak); a closely comparable mid-sized Italian peer in dermatology product development and commercialization.
• Giuliani S.p.A. Milan-based Italian pharmaceutical company with a strong dermatology, gastrointestinal, and consumer health portfolio; closest Italian mid-market peer in size, channel mix (pharmacy), and therapeutic focus on skin and gut.

Broad incumbents

• Recordati: Milan-listed Italian specialty pharmaceutical group with a sizable dermatology franchise and broader European specialty footprint; represents the scaled-up Italian pharma peer profile and a potential acquirer/partner benchmark.
• Menarini Group: Florence-based privately-held Italian pharmaceutical group with broad dermatology, cardiology, and consumer health portfolios; comparable as a large Italian pharma player distributing via European pharmacy channels.
• Galderma: Global dermatology pure-play (Nestlé Skin Health/OrbiPei heritage) covering prescription, aesthetics, and consumer skincare; relevant incumbent peer given IDI's parallel span across Rx dermatology, medical devices, and dermocosmetics.
• Pierre Fabre Dermatologie: French pharmaceutical and dermo-cosmetic group with one of Europe's largest dermatology divisions (Ducray, A-Derma, Avène); comparable in combining Rx dermatology with dermocosmetic brands across European pharmacy channels.

Others

• Polifarma S.p.A. Italian pharmaceutical company and IDI's key national distribution partner for pharmacy channels; included as an adjacent/ecosystem peer given its central role in IDI's commercial reach and potential vertical-integration counterparty.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/FarmaceuticiIdi
• Facebookfacebook.com/IDIFarmaceuticiofficial
• Instagraminstagram.com/idifarmaceuticiofficial

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDI Farmaceutici